Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chambéry
Clinical trial register · France

Clinical Trials in Chambéry, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9731 matching records held by the registry are in this view. Synced 02 Nov 2026, 03:18 UTC
9731
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1028
Lead sponsors
across recruiting studies
Top sites
Paris 2829 Lyon 1396 Bordeaux 1393 Marseille 1295 Lille 1283
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Centre Hospitalier Metropole Savoie7 Hospices Civils de Lyon6 UNICANCER5 The Lymphoma Academic Research Organisation5 University Hospital, Grenoble4
Site location
Paris2829 Lyon1396 Bordeaux1393 Marseille1295 Lille1283
All 804 locations
Target enrolment
to

Trials with a site in Chambéry

72 of 9731 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
The Lymphoma Academic Research Organisation
Phase 2
44
Angers, Caen, Chambéry, Clermont-Ferrand, La Roche-sur-Yon, Le Mans, Lille, Lyon
2026-12-31
Not yet open
Assessment of the Preventive Effect of Defusing on Traumatic Kindling
NCT07850193Acute Stress Disorder, Post Traumatic Stress Disorder PTSD
Hospices Civils de Lyon
Not applicable
70
Chambéry, Lyon, Metz-Tessy, Paris
2026-11-01
Not yet open
University Hospital, Grenoble
Not applicable
987
Annecy, Bordeaux, Chambéry, La Roche-sur-Yon, Lyon, Nancy, Nantes, Rennes
2026-10-01
Recruiting
Evaluation of Depression Screening Methods Administered by Registered Nurses in Chronic Hemodialysis Patients
NCT07651436Depressive Disorders, End-stage Chronic Kidney Disease Treated With Hemodialysis
Centre Hospitalier Annecy Genevois
Not applicable
450
Annecy, Chambéry
2026-06-26
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
75
Saint-Denis, Annecy, Bordeaux, Caen, Chambéry, Clermont-Ferrand, Dijon, Grenoble
2026-05-28
Recruiting
University Hospital, Grenoble
Observational
63
Annecy, Chambéry, Grenoble
2026-04-15
Recruiting
University Hospital, Lille
Not applicable
66
Lille, Tours, Amiens, Brest, Bron, Caen, Chambéry, Clermont-Ferrand
2026-03-10
Recruiting
Centre Hospitalier Metropole Savoie
Not applicable
36
Chambéry
2026-02-04
Recruiting
Centre Hospitalier Metropole Savoie
Not applicable
86
Annecy, Chambéry
2026-01-22
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
1,052
Saint-Etienne, Annecy, Besançon, Bordeaux, Brest, Chambéry, Créteil, Dijon
2025-12-17
Recruiting
Amber Implants B.V.
Not applicable
148
Chambéry
2025-11-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Marseille, Caen, Vandœuvre-lès-Nancy, Pau, Chambéry, Amiens, Paris
2025-10-08
Recruiting
The Value of Standardized Respiratory Rate Monitoring Exercises During Rheumatological Injection Procedures
NCT07172984Rheumatological Injection, Pain Management, Respiratory Monitoring
Centre Hospitalier Metropole Savoie
Not applicable
136
Chambéry
2025-09-19
Recruiting
Centre Hospitalier Metropole Savoie
Not applicable
36
Chambéry
2025-09-04
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Ars-Laquenexy, Besançon, Boulogne-Billancourt, Brest, Bron, Caen, Chalon-sur-Saône, Chambéry
2025-07-22
Recruiting
Centre Hospitalier Metropole Savoie
Not applicable
1,400
Chambéry, Bassens, Francin
2025-06-26
Recruiting
Groupe Hospitalier Mutualiste de Grenoble
Observational
301
Grenoble, Voiron, Chambéry
2025-06-19
Recruiting
Groupe Francais De Pneumo-Cancerologie
Phase 2
45
Brest, Caen, Chambéry, Colmar, Créteil, Dijon, Épagny, La Chaussée-Saint-Victor
2025-06-19
Recruiting
Identification of Pre-surgical Phenotypic Indicators Predictive of Quality of Life Trajectories in Obese Patients Following Bariatric Surgery
NCT06951893Obesity, Morbid, Obesity and Overweight, Bariatric Surgery, Bariatric Surgery Patients
Centre Hospitalier Metropole Savoie
Not applicable
165
Chambéry
2025-06-17
By invitation
University Hospital, Grenoble
Not applicable
240
Chambéry, Grenoble
2025-05-01
Recruiting
AstraZeneca
Phase 3
830
Angers, Avignon, Boulogne-Billancourt, Caen, Chambéry, Dijon, La Tronche, Limoges
2025-04-10
Recruiting
Hospices Civils de Lyon
Not applicable
66
Annecy, Chambéry, Lyon, Montpellier, Nîmes, Toulouse
2025-03-14
Recruiting
Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
NCT06738771Pseudomonas Infections, Pseudomonas Aeruginosa, Prognosis, Drug Resistance, Multiple, Bacterial
Centre Hospitalier Régional d'Orléans
Observational
600
Amiens, Argenteuil, Bayonne, Besançon, Béthune, Bobigny, Bourgoin, Chambéry
2025-03-11
Recruiting
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Phase 2
30
Aix-en-Provence, Marseille, Toulon, Angers, Bordeaux, Brest, Caen, Chambéry
2024-10-01
Recruiting
GFPC Investigation
Phase 4
500
Aix-en-Provence, Avignon, Bastia, Brest, Caen, Chambéry, Cherbourg, Clermont-Ferrand
2024-09-26
Recruiting
AbbVie
Phase 3
170
Metz, Créteil, Paris, St-Priest-en-Jarez, Nice, Bayonne, Chambéry, Amiens
2024-08-05
Recruiting
Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments
NCT06274268Sarcopenia, Oncology, Physical Inactivity, Toxicity Due to Chemotherapy
Centre Hospitalier Metropole Savoie
Not applicable
700
Chambéry
2024-06-24
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Avignon, Bayonne, Besançon, Bordeaux, Cahors, Chambéry, Clermont-Ferrand, Créteil
2024-06-07
Not yet open
University Hospital, Grenoble
Observational
90
Saint-Égrève, Chambéry, Grenoble
2024-05-13
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Amiens, Bayonne, Brest, Chambéry, Le Kremlin-Bicêtre, Marseille, Nantes, Paris
2024-03-29
Recruiting
Hospices Civils de Lyon
Observational
100
Saint-Priest-en-Jarez, Chambéry, Clermont-Ferrand, Lyon
2024-02-20
Recruiting
Federation Francophone de Cancerologie Digestive
Observational
600
Bayonne, Beauvais, Besançon, Boujan-sur-Libron, Boulogne-sur-Mer, Chambéry, Cholet, Compiègne
2024-02-12
Recruiting
Centre Francois Baclesse
Not applicable
300
Bordeaux, Briis-sous-Forges, Caen, Chambéry, Clermont-Ferrand, Dijon, Grenoble, Limoges
2024-02-09
Recruiting
Centre Hospitalier Annecy Genevois
Observational
400
Annecy, Bron, Chambéry, Clermont-Ferrand, Grenoble, Lyon, Saint-Etienne, Villeurbanne
2023-12-14
Active, closed
Poitiers University Hospital
Phase 3
170
Angers, Annecy, Bayonne, Brest, Brive-la-Gaillarde, Chambéry, Créteil, La Rochelle
2023-12-01
Active, closed
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
67
Abbeville, Amiens, Angers, Besançon, Bordeaux, Boulogne-Billancourt, Caen, Chambéry
2023-11-17
Recruiting
Amgen
Phase 3
750
Bayonne, Besançon, Boulogne-Billancourt, Brest, Caen, Chambéry, Créteil, La Roche-sur-Yon
2023-11-16
Active, closed
Centre Antoine Lacassagne
Phase 2
19
Amiens, Angers, Bordeaux, Caen, Chambéry, Clamart, Limoges, Nancy
2023-06-03
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
850
Chambéry, Clermont-Ferrand, Grenoble, Le Puy-en-Velay, Lyon, Privas, Roanne, Saint-Etienne
2023-04-25
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Caen, Chambéry, Le Mans, Lille, Rennes
2023-02-03
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
600
Angers, Avignon, Bayonne, Bordeaux, Caen, Chambéry, Cholet, Créteil
2022-10-27
Recruiting
Hospices Civils de Lyon
Not applicable
204
Amiens, Angers, Argenteuil, Avignon, Bayonne, Bordeaux, Chambéry, Clermont-Ferrand
2022-08-01
Recruiting
University Hospital, Brest
Observational
322
Angers, Brest, Caen, Chambéry, Lorient, Nantes, Quimper, Rennes
2022-06-21
Active, closed
Intergroupe Francophone du Myelome
Observational
180
Annecy, Chambéry, Dijon, Dunkirk, La Roche-sur-Yon, Le Kremlin Bicètre, Le Mans, Lens
2022-05-18
Recruiting
UNICANCER
Phase 3
300
Avignon, Bayonne, Besançon, Beuvry, Bordeaux, Brest, Caen, Chambéry
2022-04-19
Active, closed
Novo Nordisk A/S
Phase 3
153
Chambéry, Le Kremlin-Bicêtre, Paris
2022-03-24
Recruiting
University Hospital, Clermont-Ferrand
Not applicable
180
Amiens, Aurillac, Bayonne, Bordeaux, Chambéry, Clermont-Ferrand, Grenoble, Issoire
2022-03-21
Active, closed
Chronic Pain and Hemophilia
NCT05202951Chronic Pain, Hemophilia
University Hospital, Clermont-Ferrand
Observational
350
Bordeaux, Caen, Chambéry, Clermont-Ferrand, Grenoble, Lille, Lyon, Nantes
2022-02-28
Active, closed
Hoffmann-La Roche
Phase 3
478
Bayonne, Chambéry, Créteil, Lille, Marseille, Montpellier, Nantes, Nice
2021-10-27
Recruiting
Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET
NCT04954820Neuroendocrine Tumors, Intestinal Well Differentiated Endocrine Tumor, Progressive Disease
DrugLutathera
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
146
Angers, Bordeaux, Brest, Bron, Caen, Chambéry, Clermont-Ferrand, Clichy
2021-10-18
Active, closed
Study of Lacutamab in Peripheral T-cell Lymphoma
NCT04984837Peripheral T Cell Lymphoma, Relapse/Recurrence
DrugsOxaliplatine·Gemcitabine
The Lymphoma Academic Research Organisation
Phase 2
49
Amiens, Angers, Avignon, Bayonne, Bordeaux, Caen, Chambéry, Clermont-Ferrand
2021-10-05
Recruiting
Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC
NCT05122806Non-small Cell Lung Cancer, ALK Gene Rearrangement Positive
Groupe Francais De Pneumo-Cancerologie
Not applicable
100
Saint-Denis, Aix-en-Provence, Amiens, Angers, Annecy, Brest, Caen, Chambéry
2021-09-22
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
141
Avignon, Bayonne, Bordeaux, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon
2021-06-11
Recruiting
PROADAPT-ovary/EWOC-2
NCT04284969Ovarian Cancer, Surgery
Hospices Civils de Lyon
Not applicable
292
Bordeaux, Chambéry, Dijon, Lyon, Pierre-Bénite, Pringy, Saint-Priest-en-Jarez, Villejuif
2021-06-03
Active, closed
University Hospital, Brest
Phase 3
349
Aix-en-Provence, Amiens, Angers, Brest, Caen, Chambéry, Créteil, La Roche-sur-Yon
2020-12-22
Active, closed
Groupe Francais De Pneumo-Cancerologie
Observational
413
Aix-en-Provence, Amiens, Angers, Annecy, Brest, Chambéry, Champigny-sur-Marne, Chauny
2020-12-18
Active, closed
AbbVie
Phase 3
330
Nice, Nîmes, Pessac, Nantes, Pierre-Bénite, Chambéry, Angers, Paris
2020-08-31
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
240
Bordeaux, Perpignan, Pierre-Bénite, Angers, Chambéry, Corbeil-Essonnes, Grenoble, Le Mans
2020-08-20
Recruiting
RETRO-PROSPECTIVE POSTMARKET CLINICAL STUDY FOR FX SHOULDER SOLUTIONS SHOULDER SYSTEMS
NCT07558590Humeral Fracture, Proximal, Glenohumeral Osteoarthritis, Avascular Necrosis of the Head of Humerus, Rotator Cuff Tear
FX Solutions
Observational
1,004
Amiens, Angers, Besançon, Biarritz, Caen, Caluire-et-Cuire, Chambéry, Colmar
2020-06-01
Recruiting
Centre Francois Baclesse
Phase 3
368
Pointe à Pitre, Angers, Bordeaux, Brest, Caen, Chambéry, Clermont-Ferrand, Dijon
2020-03-02
Recruiting
Centre Hospitalier de PAU
Observational
1,200
Annecy, Bayonne, Bobigny, Bordeaux, Chalon-sur-Saône, Chambéry, Clermont-Ferrand, Créteil
2019-09-20
Recruiting
Spine Bone Cements Outcomes - Post Market Follow-up
NCT06367582Vertebral Fracture, Compression Fracture, Osteoporotic Fractures
Teknimed
Observational
500
Strasbourg, Mainvilliers, Toulouse, Le Mans, Chambéry
2019-09-04
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Amiens, Angers, Argenteuil, Bayonne, Besançon, Bobigny, Chambéry, Chesnay
2019-03-01
Recruiting
REal World Data in LYmphoma and Survival in Adults
NCT03869619Diffuse Large B Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL)
Hospices Civils de Lyon
Observational
6,000
Arras, Besançon, Bordeaux, Bourgoin, Caen, Chambéry, Clermont-Ferrand, Créteil
2018-11-14
Active, closed
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
NCT03143322Metastatic Breast Cancer, Metastatic Lung Cancer, Metastatic Prostate Cancer, Bone Metastases
UNICANCER
Not applicable
168
Angers, Arras, Avignon, Beuvry, Bordeaux, Chambéry, Chambray-lès-Tours, Creil
2018-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Suresnes, Pierre-Bénite, Strasbourg, Toulouse, Limoges, Chambéry, Pringy, Rouen
2018-04-24
Recruiting
Octapharma
Observational
200
Besançon, Chambéry, Chambray-lès-Tours, Le Mans, Montmorency, Nantes, Paris, Saint-Priest-en-Jarez
2018-02-13
Active, closed
The Lymphoma Academic Research Organisation
Phase 1/2
214
Clermont-Ferrand, Argenteuil, Avignon, Besançon, Bordeaux, Chambéry, Créteil, Dijon
2016-10
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Amiens, Angers, Bayonne, Bordeaux, Brest, Bron, Caen, Chambéry
2013-03-18
Active, closed
UNICANCER
Phase 2
120
Angers, Avignon, Besançon, Bordeaux, Brest, Caen, Chambéry, Créteil
2012-12
Active, closed
UNICANCER
Not applicable
1,006
Amiens, Bordeaux, Brivé, Caen, Chambéry, Créteil, Dechy, Grenoble
2010-12-27
Active, closed
UNICANCER
Not applicable
500
Angers, Bordeaux, Caen, Chambéry, Chambray-lès-Tours, Créteil, Lyon, Marseille
2008-10
Rows per page Showing 1–72 of 72
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 2 November 2026. https://priyalifescience.com/clinical-trials-france/city/chamb-ry

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,731 studies in total at the last sync on 02 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 72 of those studies with a site in Chambéry.

How many clinical trials are recruiting in Chambéry?

44 of the 72 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:18 UTC sync. A further 4 have not yet opened recruitment, 23 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chambéry), 72 studies
PhaseStudiesRecruitingShare
Not applicable241833.3%
Observational181425%
Phase 318725%
Phase 29312.5%
Phase 4222.8%
Phase 1/2101.4%

Most active sponsors

Lead sponsors with the most studies (Chambéry)
Lead sponsorStudiesRecruiting
Centre Hospitalier Metropole Savoie77
Hospices Civils de Lyon65
The Lymphoma Academic Research Organisation50
UNICANCER51
University Hospital, Grenoble41
Groupe Francais De Pneumo-Cancerologie32
AbbVie21
Alexion Pharmaceuticals, Inc.21
Centre Francois Baclesse22
Centre Hospitalier Annecy Genevois22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.